home.aspx
 
EVENTS

Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 26-30, 2020
36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is organized by International Society for Pharmacoepidemiology (ISPE) and will be held from Aug 26 - 30, 2020 at Estrel Berlin, Berlin, Germany.

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Bupa

SHARESHARESHARE
Bupa's purpose is helping people live longer, healthier, happier lives. With no shareholders, our customers are our focus. We reinvest profits into providing more and better healthcare for the benefit of current and future customers. Health insurance is at the core of our business globally. In some markets we also operate clinics, dental centres, hospitals, care homes and villages; giving us greater insight into how health systems work and enabling us to better meet the needs of our customers.
SHARESHARESHARE

RELATED NEWS


AstraZeneca, along with its global biologics research and development arm, MedImmune, will present the strength and depth of its translational science, which is expected to deliver the Company's next wave of innovative oncology medicines, at the American Association for Cancer Research (AACR) Annual Meeting in Washington DC, US, 1-5 April 2017....

READ MORE

Shares of Intercept Pharmaceuticals have exploded this morning after the company announced positive news from its Phase III nonalcoholic steatohepatitis (NASH) trial. The stock has shot up more than 20 percent in premarket trading to $133 per share as investors see the potential for the first approved NASH treatment in the U.S. The company reported that its REGENERATE study of obeticholic acid (OCA) in patients with liver fibrosis due to NASH met its primary endpoint. The company said that a onc...

READ MORE

The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections. "Fluoroquinolones have risks and benefits that should be considered very carefully," said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation...
WORLDPHARMANEWS.COM
READ MORE

IBM is stopping development and sales of its tool that utilizes Watson AI to help pharmaceutical companies find new drugs, according to a STAT report. A source told STAT that the product, Watson for Drug Discovery, wasn’t yielding large enough financial returns. The source noted that some IBM employees were recently informed of the decision, and it prompted a process to revaluate IBM’s work in the pharma industry and look at other opportunities. IBM did not immediately respond to a r...

READ MORE

There have been calls for another stay on the rollout of Australia’s troubled My Health Record digital patient data scheme after figures revealed an increase in the number of data breaches. The Sydney Morning Herald reported that the system sustained 42 data breaches last financial year, just as the country’s government struggled to convince people, not to opt-out of the system. My Health Record has been roundly criticized as it is based around an “opt-out” principle, and...

READ MORE

Research led by the University of Birmingham indicates that a GLP-1 agonist drug, currently used to lower blood sugar in people with type II diabetes, could be repurposed to treat raised brain pressure. The condition commonly develops in emergency situations such as traumatic brain injury, hydrocephalus and stroke, but also plays a key role in Idiopathic Intracranial Hypertension (IIH), which can cause daily headaches, severely raised pressure around the nerves in the eye, and permanent vision l...

READ MORE

EVENTS

Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 26-30, 2020
36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is organized by International Society for Pharmacoepidemiology (ISPE) and will be held from Aug 26 - 30, 2020 at Estrel Berlin, Berlin, Germany.

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.